# Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment

> **NCT01529242** · PHASE3 · TERMINATED · sponsor: **EMS** · enrollment: 17 (actual)

## Conditions studied

- Cutaneous Hypersensitivity

## Interventions

- **DRUG:** Desloratadine + Prednisolone
- **DRUG:** Dexchlorpheniramine + Betamethasone

## Key facts

- **NCT ID:** NCT01529242
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2016-08
- **Final completion:** 2016-10-20
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** By sponsor decision due to difficulty of recruitment
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01529242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01529242, "Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01529242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*